Imatinib placebo

DRUG2 trials

Sponsors

Karolinska Institutet, Novartis Pharmaceuticals

Conditions

Acute ischemic strokeRheumatoid Arthritis

Phase 2

A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.

CompletedNCT00154336

Novartis PharmaceuticalsRheumatoid Arthritis

Start: 2004-07-31End: 2005-08-31Updated: 2017-04-25

Phase 3

A phase 3, randomised, double-blind, placebo-controlled, parallel-arm efficacy trial of Imatinib in acute ischaemic stroke

SuspendedCTIS2023-506178-11-00

Karolinska InstitutetAcute ischemic stroke

Start: 2025-11-11Target: 680Updated: 2023-11-07